Actively Recruiting
Monitoring for Early Signs of Complications During Immunotherapy in Blood Cancers Using Vital Sign Tracking and Immune Response Analysis
Led by Rigshospitalet, Denmark · Updated on 2026-05-15
100
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating how to better identify patients with hematologic cancers who may develop serious complications after immunotherapy treatments such as chimeric antigen receptor T-cell therapy CART or bispecific antibodies BsAbs. The study aims to improve early detection of conditions like cytokine release syndrome CRS, a common and potentially severe side effect of these treatments. By understanding physiological and immunological changes, the research hopes to enhance patient monitoring and care. The study combines three research projects continuous wireless monitoring of vital signs using the WARD system, immune function testing through TruCulture and Duraclone, and clinical observation in a specialized phase one unit. WARD continuously tracks heart rate, respiratory rate, blood pressure, and oxygen saturation using wearable devices. The phase one unit allows safe administration and close monitoring during treatment. Immune profiling measures markers of inflammation to explore links with clinical complications. Participants will undergo continuous vital sign monitoring and immune testing during and up to 30 days after immunotherapy. Researchers will collect data including ECGs, blood pressure readings, oxygen saturation, and immune responses to develop risk models predicting severe complications. Alarms notify health personnel of abnormal vital signs for timely intervention. The primary outcome is occurrence of cytokine release syndrome within 30 days, with secondary outcomes including immune response and physiological changes. The study will last through at least July 2027.
CONDITIONS
Brief Title
Early Detection of Complications During Immunotherapy for Haematological Malignancy
Research Team
S
Sandra Egedie Lyby Taylor Pitter, MD
E
Eske K Aasvang, Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here